\
&
Contact us
\
&
Contact us
This was 3 years ago
LocationOnline
ProgrammesThe European Health Forum Gastein (EHFG) is a European health policy platform, which aims to provide a neutral and inclusive platform for discussions and advancement of health, solidarity and equity in the EU and beyond.
Every year, EHFG’s annual conference brings together leading experts, decision-makers and members of the European public health community. This year’s conference main theme is ‘health at the heart of a resilient future for Europe’ as health has become a top priority on Europe’s political agenda in the wake of the unprecedented COVID-19 crisis.
Take part in inspiring discussions, focusing on next challenges on the horizon, complex health systems and joining forces for health and make use of the networking spaces offered during the conference.
More information and registration on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
